Proposal for standardization of 123I-metaiodobenzylguanidine (MIBG) cardiac sympathetic imaging by the EANM Cardiovascular Committee and the European Council of Nuclear Cardiology

Albert Flotats, Ignasi Carrió, Denis Agostini, Dominique Le Guludec, Claudio Marcassa, Michael Schaffers, G. Aernout Somsen, Mustafa Unlu, Hein J. Verberne

Research output: Contribution to journalReview articleResearchpeer-review

216 Citations (Scopus)

Abstract

This proposal for standardization of 123I- metaiodobenzylguanidine (iobenguane, MIBG) cardiac sympathetic imaging includes recommendations for patient information and preparation, radiopharmaceutical, injected activities and dosimetry, image acquisition, quality control, reconstruction methods, attenuation, scatter and collimator response compensation, data analysis and interpretation, reports, and image display. The recommendations are based on evidence coming from original or scientific studies whenever possible and as far as possible reflect the current state-of-the-art in cardiac MIBG imaging. The recommendations are designed to assist in the practice of performing, interpreting and reporting cardiac sympathetic imaging. The proposed standardization does not include clinical indications, benefits or drawbacks of cardiac sympathetic imaging, and does not address cost benefits or cost effectiveness; however, clinical settings of potential utility are mentioned. Standardization of MIBG cardiac sympathetic imaging should contribute to increasing its clinical applicability and integration into current nuclear cardiology practice. © 2010 EANM.
Original languageEnglish
Pages (from-to)1802-1812
JournalEuropean Journal of Nuclear Medicine and Molecular Imaging
Volume37
Issue number9
DOIs
Publication statusPublished - 1 Jan 2010

Keywords

  • Cardiac sympathetic imaging
  • Guidelines
  • MIBG imaging

Fingerprint Dive into the research topics of 'Proposal for standardization of <sup>123</sup>I-metaiodobenzylguanidine (MIBG) cardiac sympathetic imaging by the EANM Cardiovascular Committee and the European Council of Nuclear Cardiology'. Together they form a unique fingerprint.

Cite this